Talphera, Inc. (TLPH) stock
TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.91−0.13 (-12.46%)
Close on Nov 13, 2026Market cap $47.03MP/E –Yield –
Talphera gross margin
Gross margin is gross profit as a percentage of revenue.
Talphera's gross margin for the twelve months ending Sep 30, 2022 was -680.0%. For fiscal 2021 it was -33.2%, against -11.4% the year before. The highest annual figure on record is 90.8% in fiscal 2015.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | -33.2% | −21.8 |
| FY2020 | Dec 31, 2020 | -11.4% | +186.0 |
| FY2019 | Dec 31, 2019 | -197.3% | −112.5 |
| FY2018 | Dec 31, 2018 | -84.8% | −51.5 |
| FY2017 | Dec 31, 2017 | -33.3% | −62.4 |
| FY2016 | Dec 31, 2016 | 29.0% | −61.8 |
| FY2015 | Dec 31, 2015 | 90.8% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2022 | Mar 31, 2022 | -77.4% | +26.1 |
| Q4 FY2021 | Dec 31, 2021 | -61600.0% | −61523.8 |
| Q3 FY2021 | Sep 30, 2021 | 76.4% | +111.7 |
| Q2 FY2021 | Jun 30, 2021 | -134.8% | −187.9 |
| Q1 FY2021 | Mar 31, 2021 | -103.5% | +187.9 |
| Q4 FY2020 | Dec 31, 2020 | -76.2% | +164.5 |
| Q3 FY2020 | Sep 30, 2020 | -35.3% | +218.0 |
| Q2 FY2020 | Jun 30, 2020 | 53.1% | +145.5 |
| Q1 FY2020 | Mar 31, 2020 | -291.5% | +72.7 |
| Q4 FY2019 | Dec 31, 2019 | -240.6% | −138.7 |
| Q3 FY2019 | Sep 30, 2019 | -253.3% | −121.2 |
| Q2 FY2019 | Jun 30, 2019 | -92.3% | −100.8 |
| Q1 FY2019 | Mar 31, 2019 | -364.2% | −139.4 |
| Q4 FY2018 | Dec 31, 2018 | -102.0% | −72.0 |
| Q3 FY2018 | Sep 30, 2018 | -132.1% | −95.6 |
| Q2 FY2018 | Jun 30, 2018 | 8.4% | +41.7 |
| Q1 FY2018 | Mar 31, 2018 | -224.8% | −192.1 |
| Q4 FY2017 | Dec 31, 2017 | -30.0% | −80.9 |
| Q3 FY2017 | Sep 30, 2017 | -36.4% | – |
| Q2 FY2017 | Jun 30, 2017 | -33.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -32.7% | – |
| Q4 FY2016 | Dec 31, 2016 | 50.9% | – |
See a number that looks wrong?